Takara Bio, Inc expands GMP facility to accommodate a variety of modalities and strengthen supply chain
San Jose, CA—February 24, 2022—Takara Bio Inc. will open an expansion of its manufacturing facility, the Center for Gene and Cell Processing (CGCP), at the company’s headquarters in Shiga, Japan. The expansion of the facility, which went into operation in 2020, features increased production capacity. New equipment includes 200 L bioreactors, 2,000 L fermenters, and large flow centrifuge and purification systems.
The GMP facility expansion will address a growing demand for CDMO services. It will also meet the need for a wider variety of manufacturing modalities and raw materials. Manufactured products will include DNA and RNA vaccines, gene therapy and cancer immunotherapy drugs, and regenerative medicines. Full operation of the CGCP is planned for 2023.
With our state-of-the-art GMP manufacturing facilities in Japan and Europe, Takara Bio USA provides services for viral vector production, cell processing, clinical-grade human embryonic stem cell line derivation, quality testing, and cell banking. These gene and cell therapy manufacturing services, carried out by a global team of seasoned experts, provide support throughout the entire process of development and manufacturing to help researchers accelerate their translational and clinical discoveries.
Read more about the CGCP facility on Takara Bio Inc.’s news release page.
Sign up to download our brochure
Highlights of this brochure:
- Our state-of-the-art GMP manufacturing facilities
- Process development workflow
- Investigational product manufacturing services:
- Cell banking
- Cell processing
- Viral vector production
- Quality testing
Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2023 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.